Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variation among Consent Forms for Clinical Whole Exome Sequencing

8 Jul 2017

Abstract excerpt

The goal of this study was to explore variation among informed consent documents for clinical whole exome sequencing (WES) in order to identify the level of consistency with the recommendations from the American College of Medical Genetics and Genomics (ACMG) and the Presidential Commission for the Study of Bioethical Issues (Bioethics Commission) regarding informed consent for clinical WES. Recommendations were...

Topics

Join the communities discussing this publication.

Ethics in Clinical Research
Genomics and Rare Diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 28689263
DOI: 10.1007/s10897-017-0127-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variation among Consent Forms for Clinical Whole Exome SequencingPMID 28689263Read ↗

Readability of informed consent forms for whole-exome and whole-genome sequencingSemantic proximity Read ↗

How do consent forms for diagnostic high‐throughput sequencing address unsolicited and secondary findings? A content analysisSemantic proximity Read ↗

Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratoriesSemantic proximity Read ↗

Experiences with obtaining informed consent for genomic sequencingSemantic proximity Read ↗

Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms.Semantic proximity Read ↗

Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patientsSemantic proximity Read ↗

Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada?Semantic proximity Read ↗

Implementing Electronic Informed Consent in Rare Disease GenomicsSemantic proximity Read ↗

A Closer Look at the Recommended Criteria for Disclosing Genetic Results: Perspectives of Medical Genetic Specialists, Genomic Researchers, and Institutional Review Board ChairsSemantic proximity Read ↗

Defining the Critical Educational Components of Informed Consent for Genetic Testing: Views of US-Based Genetic Counselors and Medical GeneticistsSemantic proximity Read ↗

Points to consider for informed consent for genome/exome sequencingSemantic proximity Read ↗

Informed consent for exome sequencing research in families with genetic disease: The emerging issue of incidental findingsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.